AIM
Aim Immunotech Inc
AMEX · Biotechnology
$1.14
-0.09 (-7.32%)
Open$1.25
Previous Close$1.23
Day High$1.25
Day Low$1.06
52W High$24.90
52W Low$10.94
Volume—
Avg Volume162.0K
Market Cap3.74M
P/E Ratio38.93
EPS$0.50
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+1,838.6% upside
Current
$1.14
$1.14
Target
$22.10
$22.10
$15.13
$22.10 avg
$31.02
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.49M | 1.31M | 1.61M |
| Net Income | -287,322 | -292,011 | -275,194 |
| Profit Margin | -19.3% | -22.2% | -17.1% |
| EBITDA | -396,733 | -341,169 | -390,753 |
| Free Cash Flow | -189,259 | -173,511 | -203,411 |
| Rev Growth | +0.1% | +20.5% | -9.2% |
| Debt/Equity | 0.83 | 0.83 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |